Guangdong Transtek Medical Electronics Co.Ltd(300562) 2022 announcement securities code: Guangdong Transtek Medical Electronics Co.Ltd(300562) securities abbreviation: Guangdong Transtek Medical Electronics Co.Ltd(300562) Announcement No.: 2022018 Guangdong Transtek Medical Electronics Co.Ltd(300562)
Announcement on 2021 profit distribution plan
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Transtek Medical Electronics Co.Ltd(300562) (hereinafter referred to as "the company") held the 27th meeting of the third board of directors and the 25th meeting of the third board of supervisors on March 17, 2022, and deliberated and adopted the proposal on the company's profit distribution plan in 2021. This proposal still needs to be submitted to the company's 2021 annual general meeting for deliberation. The independent directors of the company expressed their independent opinions on the profit distribution plan. The basic information of the plan is hereby announced as follows:
1、 Financial overview of 2021
Audited by Lixin Certified Public Accountants (special general partnership), the consolidated accounting statements of the company in 2021 realized a net profit of 886881545 yuan attributable to the shareholders of the listed company, of which the parent company realized a net profit of 1678830326 yuan. According to the relevant provisions of the company law of the people's Republic of China and the articles of association, after withdrawing 10% of the statutory surplus reserve of 167883033 yuan according to the parent company's net profit of 1678830326 yuan in 2021, as of December 31, 2021, the distributable profit of the company's consolidated statements was 23778655350 yuan, the distributable profit of the parent company was 28269765460 yuan, and the profit available for distribution to shareholders in 2021 was 718998512 yuan. According to the principle that the profit distribution should be based on the lower of the distributable profit of the parent company and the distributable profit of the consolidated financial statements, the profit available for shareholders of the company as of December 31, 2021 is 23778655350 yuan.
2、 Basic contents of 2021 profit distribution plan
Based on the company's development strategy and development stage, comprehensively considering the company's current operating conditions and future development needs, and in accordance with the principle of encouraging enterprises to pay cash dividends and sharing the company's operating results with shareholders, the following distribution plan is hereby formulated:
Guangdong Transtek Medical Electronics Co.Ltd(300562) the announcement in 2022 is based on the total number of 214701188 shares of the company's share capital, and the cash dividend is 0.10 yuan (tax included) for every 10 shares. The total cash dividend in 2021 is 214701188 yuan. Do not give bonus shares or convert capital reserve into share capital; The remaining undistributed profits are carried forward to the next year.
If the total share capital of the company changes before the implementation of the profit distribution plan, the company will disclose the distribution proportion calculated according to the latest total share capital of the company in the profit distribution implementation announcement in accordance with the principle of "fixed total cash dividends".
3、 Opinions of independent directors
After careful review, the independent directors agreed that the company's profit distribution plan for 2021 was in line with the company law of the people's Republic of China, the articles of association and other relevant provisions, in line with the current actual situation of the company, and did not damage the interests of the company's shareholders, especially the minority shareholders. Therefore, all independent directors of the company unanimously agreed to the 2021 profit distribution plan proposed by the board of directors and agreed to submit the profit distribution plan to the general meeting of shareholders for deliberation.
4、 Opinions of the board of supervisors
After review, the board of supervisors believes that the 2021 profit distribution plan of the company combines the current actual situation of the company, complies with the relevant provisions on dividends in the company law of the people's Republic of China and the articles of association, complies with the company's profit distribution policy and the dividend return plan for shareholders, and has legitimacy, compliance and rationality. All supervisors unanimously agree with the 2021 profit distribution plan of the company.
5、 Relevant risk tips
This profit distribution plan needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation, and can be implemented only after it is deliberated and approved. Please pay attention to the investment risks.
It is hereby announced.
Guangdong Transtek Medical Electronics Co.Ltd(300562) board of directors
March 19, 2002
